Position Summary:

Reporting to the Senior Director, Financial Planning & Analysis, the Senior Manager, Commercial Financial Planning & Analysis (FP&A) will partner closely with Commercial teams—including Sales, Marketing, Market Access and Commercial Operations—to drive strategic business objectives through planning, analysis, and actionable insights. This role supports all aspects of financial management, including expense planning, monthly and quarterly variance analysis, and preparation of management commentary. The Senior Manager, Commercial FP&A builds and maintains financial models, delivers ad-hoc analyses, and provides proactive updates to inform decision-making. Acting as a liaison between Finance and Commercial leadership, this position develops strong partnerships across the organization and plays a critical role in supporting the company’s growth and performance.

Responsibilities:

Partner with Commercial leaders across Sales, Marketing, Market Access, and Commercial Operations to track initiatives against budgets and forecast, ensuring alignment with organizational goals.
Lead the development, maintenance, and management of Commercial operating expense budgets and forecasts.
Build and update financial models to monitor Commercial spending against budget and forecasts to evaluate commercial performance, inform initiatives, and support data-driven decisions.
Prepare monthly and quarterly financial reporting packages, including variance analysis, forecasting updates, and management commentary.
Support month- and quarter-end close by preparing accruals, performing variance analysis, and providing management commentary.
Perform ad hoc financial analyses to support strategic Commercial initiatives.
Analyze key business drivers and emerging trends, proactively communicating financial risks, opportunities, and recommendations to Commercial and Finance leadership.
Build and maintain strong cross-functional relationships to improve financial visibility, strengthen decision-making, and support the achievement of Commercial objectives.
Perform other duties and special projects as assigned.

Qualifications:

Eight plus (8+) years of progressive experience in FP&A, finance or accounting, with demonstrated experience supporting Commercial functions such as Sales, Marketing, Access and Commercial Operations; prior biotech/pharma industry experience preferred.
Bachelor’s degree in accounting, finance, business administration or a related field required; advanced degree (MBA or equivalent) preferred.
Track record of partnering with Commercial teams (Sales, Marketing, Operations, Market Access) to drive strategic and financial objectives.
Experience supporting pharmaceutical product launches strongly preferred.
Advanced Microsoft Office skills, with expert-level Excel (pivot tables, lookups, complex formulas).
Proven ability to build and maintain financial models, perform complex analytics, and translate data into actionable business insights.
Highly organized, self-starter, and strategically minded; able to manage multiple priorities and tight deadlines.
Strong analytical and problem-solving skills; able to identify issues, gather relevant data, and provide solution-oriented recommendations.
Excellent verbal and written communication skills; able to explain complex concepts clearly and present confidently to all levels of management.
Strong interpersonal and influencing skills; able to build trusted partnerships and align stakeholders across functions.
Detail-oriented with high accountability for results and awareness of organizational impact.

About Us:

Celcuity is a publicly traded commercial-stage biotechnology company developing targeted therapies for multiple solid tumor indications. The company's first FDA-approved product is REVTORPYK (gedatolisib), targets all class I isoforms of PI3K and the mTOR complexes to comprehensively block the PAM pathway. The PAM pathway is an important signaling pathway involved in many cancers and has historically been challenging to target.

A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- locally advanced or metastatic breast cancer (“ABC”), supported FDA approval of REVTORPYK for use in patients without a PIK3CA mutation detected. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going.

Celcuity is an Equal-Opportunity Employer.

Celcuity is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are competitive. For this role, the anticipated base pay range is $145,000 – $165,000 DOE. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate’s geography, qualifications, skills, and experience.

The successful candidate will be eligible for an annual performance incentive bonus and a new hire equity package. Celcuity also offers various benefits offerings, including, but not limited to, medical, dental, vision insurance, 401(k) match, PTO, and paid holidays.

Notice to Recruiters/Staffing Agencies

Recruiters and staffing agencies should not contact Celcuity through this page. All recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees directly.

We require that all recruiters and staffing agencies have a fully executed, formal written agreement on file. Celcuity’s receipt or acceptance of an unsolicited resume submitted by a vendor organization to this website or employee does not constitute an actual or implied contract between Celcuity and such organization and will be considered unsolicited. Celcuity will not be responsible for related fees.